Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression

Stereological Methods. Practical methods for biological morphometry

Weibel, E. R. (1979) · Academic Press eBooks · Cited by 2,010 · see citing works

Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat

Buijs, R. M., Swaab, D. F., Dogterom, J., & van Leeuwen, F. W. (1978) · Cell and Tissue Research · doi:10.1007/bf00224932 · Cited by 1,029 · see citing works

Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin

Gillies, G. E., Linton, E. A., & Lowry, P. J. (1982) · Nature · doi:10.1038/299355a0 · Cited by 965 · see citing works

Increased Numbers of Corticotropin-Releasing Hormone Expressing Neurons in the Hypothalamic Paraventricular Nucleus of Depressed Patients

Raadsheer, F. C., Hoogendijk, W. J. G., Stam, F. C., Tilders, F. J. H., & Swaab, D. F. (2008) · Neuroendocrinology · doi:10.1159/000126778 · Cited by 667 · see citing works

Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty

Britton, D. R., Koob, G. F., Rivier, J., & Vale, M. L. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90416-7 · Cited by 534 · see citing works

Identification of the vasopressin producing and of the oxytocin producing neurons in the hypothalamic magnocellular neurosecretory system of the rat

Vandesande, F., & Dierickx, K. (1975) · Cell and Tissue Research · doi:10.1007/bf00218970 · Cited by 496 · see citing works

Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior

Stenzel‐Poore, M. P., Heinrichs, S. C., Rivest, S., Koob, G. F., & Vale, W. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02579.1994 · Cited by 468 · see citing works

Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases

Swaab, D. F., Purba, J. S., & Hofman, M. A. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.2.7852523 · Cited by 421 · see citing works

Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression

Raadsheer, F. C., van Heerikhuize, J. J., Lucassen, P. J., Hoogendijk, W. J. G., Tilders, F. J. H., & Swaab, D. F. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.9.1372 · Cited by 411 · see citing works

Corticotrophin releasing factor, grooming and ingestive behavior

Morley, J. E., & Levine, A. S. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90007-8 · Cited by 402 · see citing works

Corticotropin-releasing factor: co-expression within distinct subsets of oxytocin-, vasopressin-, and neurotensin-immunoreactive neurons in the hypothalamus of the male rat

Sawchenko, P. E., Swanson, L. W., & Vale, W. (1984) · Journal of Neuroscience · doi:10.1523/jneurosci.04-04-01118.1984 · Cited by 305 · see citing works

Seasonality and affective illness

Wehr, T. A., & Rosenthal, N. E. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.7.829 · Cited by 284 · see citing works

Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression

(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.656 · Cited by 278 · see citing works

Reflex control of magnocellular vasopressin and oxytocin secretion

Cunningham, E. T., & Sawchenko, P. E. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90032-p · Cited by 266 · see citing works

Vasopressin : principles and properties

Gash, D. M., & Boer, G. J. (1987) · Plenum Press eBooks · Cited by 250 · see citing works

[38] Assay of corticotropin releasing factor

Vale, W., Vaughan, J. M., Yamamoto, G., BRUHN, T. O., Douglas, C., Dalton, D., RIVIER, C. L., & Rivier, J. (1983) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(83)03040-2 · Cited by 246 · see citing works

Dissociation of oxytocin, vasopressin and corticotropin secretion during different types of stress

Gibbs, D. M. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90241-8 · Cited by 233 · see citing works

Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons

Bartanusz, V., Ježová, D., Bertini, L. T., Tilders, F. J. H., Aubry, J. M., & Kiss, J. Z. (1993) · Endocrinology · doi:10.1210/endo.132.2.8425502 · Cited by 222 · see citing works

Oxytocin acts as an antidepressant in two animal models of depression

Arletti, R., & Bertolini, A. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90600-x · Cited by 203 · see citing works

The vasopressin and oxytocin neurons in the human supraoptic and paraventricular nucleus; changes with aging and in senile dementia

Fliers, E., Swaab, D. F., W. Pool, C., & Verwer, R. W. H. (1985) · Brain Research · doi:10.1016/0006-8993(85)91351-4 · Cited by 190 · see citing works

Morphometry of size/volume variables and comparison of their bivariate relations in the nervous system under different conditions

Uylings, H. B. M., van Eden, C. G., & Hofman, M. A. (1986) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(86)90111-1 · Cited by 184 · see citing works

Lithium-induced nephrogenic diabetes insipidus: in vivo and in vitro studies

Singer, I. I., Rotenberg, D., & Puschett, J. B. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106900 · Cited by 179 · see citing works

Corticotrophin releasing factor may be modulated vasopressin

Gillies, G. E., & Lowry, P. (1979) · Nature · doi:10.1038/278463a0 · Cited by 174 · see citing works

Cortisol Response to a Combined Dexamethasone‐Human Corticotrophin‐Releasing Hormone Challenge in Patients with Depression

von Bardeleben, U., & Holsboer, F. (1989) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1989.tb00150.x · Cited by 161 · see citing works

Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression

Holsboer-Trachsler, E., Stohler, R., & Hatzinger, M. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90041-m · Cited by 160 · see citing works

Chapter 21 The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia

Holsboer, F., Spengler, D., & Heuser, I. (1992) · Progress in brain research · doi:10.1016/s0079-6123(08)64586-0 · Cited by 158 · see citing works

Functional neuroanatomy and neuropathology of the human hypothalamus

Swaab, D. F., Hofman, M. A., Lucassen, P. J., Purba, J. S., Raadsheer, F. C., & van de Nes, J. A. P. (1993) · Anatomy and Embryology · doi:10.1007/bf00185889 · Cited by 155 · see citing works

Particle size‐shape distributions: the general spheroid problem: II. Stochastic model and practical guide

Cruz-Orive, L. M. (1978) · Journal of Microscopy · doi:10.1111/j.1365-2818.1978.tb01162.x · Cited by 149 · see citing works

Non-pharmacological treatment of sleep and wake disturbances in aging and Alzheimer's disease: Chronobiological perspectives

Someren, E. J. W. V., Mirmiran, M., & Swaab, D. F. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90140-l · Cited by 122 · see citing works

Localization of corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus; age-dependent colocalization with vasopressin

Raadsheer, F. C., Sluiter, A. A., Ravid, R., Tilders, F. J. H., & Swaab, D. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91113-7 · Cited by 117 · see citing works

Phototherapy for Seasonal Affective Disorder

Rosenthal, N. E., Sack, D. A., Skwerer, R. G., Jacobsen, F. M., & Wehr, T. A. (1988) · Journal of Biological Rhythms · doi:10.1177/074873048800300202 · Cited by 116 · see citing works

Extrahypothalamic vasopressin and oxytocin in the human brain; presence of vasopressin cells in the bed nucleus of the stria terminalis

Fliers, E., Guldenaar, S. E. F., Wal, N. V. D., & Swaab, D. F. (1986) · Brain Research · doi:10.1016/0006-8993(86)90759-6 · Cited by 114 · see citing works

Neurohypophyseal principles and memory.

de Wied, D., & Versteeg, D. H. G. (1979) · PubMed · Cited by 103 · see citing works

The effects of separate or combined infusions of corticotrophin-releasing factor and vasopressin either intraventricularly or into the amygdala on aggressive and investigative behaviour in the rat

El-Kabir, D. R., Wyatt, M. E., Vellucci, S. V., & Herbert, J. (1990) · Regulatory Peptides · doi:10.1016/0167-0115(90)90018-r · Cited by 102 · see citing works

Diurnal and Seasonal Rhythms of Neuronal Activity in the Suprachiasmatic Nucleus of Humans

Hofman, M. A., & Swaab, D. F. (1993) · Journal of Biological Rhythms · doi:10.1177/074873049300800402 · Cited by 102 · see citing works

Oxytocin cell number in the human paraventricular nucleus remains constant with aging and in Alzheimer’s disease

Wierda, M., Goudsmit, E., Van Der Woude, P. F., Purba, J. S., Hofman, M. A., Bogte, H., & Swaab, D. F. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90081-t · Cited by 92 · see citing works

Cerebrospinal fluid neurophysins in affective illness and in schizophrenia

Linkowski, P., Geenen, V. G., Kerkhofs, M., Mendlewicz, J., & Legros, J. J. (1984) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00461555 · Cited by 89 · see citing works

Vasopressin and Cardiovascular System in Aging

Frolkis, V. V., Golovchenko, S. F., Medved, V. I., & Frolkis, R. A. (2009) · Gerontology · doi:10.1159/000212546 · Cited by 84 · see citing works

Seasonal changes in the suprachiasmatic nucleus of man

Hofman, M. A., & Swaab, D. F. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90566-p · Cited by 83 · see citing works

Sex-difference and left-right asymmetries in the prefrontal cortex during postnatal development in the rat

van Eden, C. G., Uylings, H. B. M., & van Pelt, J. (1984) · Developmental Brain Research · doi:10.1016/0165-3806(84)90186-x · Cited by 81 · see citing works

Activation of vasopressin neurons in the human supraoptic and paraventricular nucleus in senescence and senile dementia

Hoogendijk, J. E., Fliers, E., Swaab, D. F., & Verwer, R. W. H. (1985) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(85)90141-8 · Cited by 81 · see citing works

Effects of light treatment on core body temperature in seasonal affective disorder

Rosenthal, N. E., Levendosky, A. A., Skwerer, R. G., Joseph-Vanderpool, J. R., Kelly, K. A., Hardin, T. A., Kasper, S. F., DellaBella, P., & Wehr, T. A. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90018-w · Cited by 74 · see citing works

Brain oxytocin receptors mediate corticotropin-releasing hormone-induced anorexia

Olson, B. R., Drutarosky, M. D., Stricker, E. M., & Verbalis, J. G. (1991) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1991.260.2.r448 · Cited by 73 · see citing works

Blunted Prolactin Response

Judd, L. L. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290120045009 · Cited by 72 · see citing works

Cerebrospinal Fluid Vasopressin—Changes in Depression

Gjerris, A., Vendsborg, P. B., HAMMER, M., Christensen, N. J., & Rafaelsen, O. J. (1985) · The British Journal of Psychiatry · doi:10.1192/bjp.147.6.696 · Cited by 69 · see citing works

Annual variations in the vasopressin neuron population of the human suprachiasmatic nucleus

Hofman, M. A., Purba, J. S., & Swaab, D. F. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90493-y · Cited by 68 · see citing works

No vasopressin cell loss in the human hypothalamus in aging and Alzheimer's disease

Woude, P. F. V. D., Goudsmit, E., Wierda, M., Purba, J. S., Hofman, M. A., Bogte, H., & Swaab, D. F. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)80003-a · Cited by 63 · see citing works

Activation of Vasopressin Neurons in Aging and Alzheimer's Disease

Lucassen, P. J., Salehi, A., Pool, C. W., Gonatas, N. K., & Swaab, D. F. (1994) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1994.tb00634.x · Cited by 62 · see citing works

Excitotoxin paraventricular nucleus lesions: stress and endocrine reactivity and oxytocin mRNA levels

Callahan, M. F., Thore, C. R., Sundberg, D. K., Gruber, K. A., O’Steen, K., & Morris, M. (1992) · Brain Research · doi:10.1016/0006-8993(92)91499-5 · Cited by 53 · see citing works

Evidence for a direct inhibitory effect of morphine on the secretion of posterior pituitary hormones

Lutz‐Bucher, B., & Koch, B. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90470-7 · Cited by 50 · see citing works

Quantification of antiserum reactivity in immunocytochemistry. Two new methods for measuring peroxidase activity on antigen-coupled beads incubated according to an immunocytoperoxidase method.

Pool, C. W., Madlener, S., Diegenbach, P. C., Sluiter, A. A., & van der Sluis, P. (1984) · Journal of Histochemistry & Cytochemistry · doi:10.1177/32.9.6205048 · Cited by 42 · see citing works

In situ hybridization for vasopressin mRNA in the human supraoptic and paraventricular nucleus; quantitative aspects of formalin-fixed paraffin-embedded tissue sections as compared to cryostat sections

Lucassen, P. J., Goudsmit, E., Pool, C. W., Mengod, G., Palacios, J. M., Raadsheer, F. C., Guldenaar, S. E. F., & Swaab, D. F. (1995) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)00152-7 · Cited by 38 · see citing works

Vasopressin levels in the cerebrospinal fluid of rats with lesions of the paraventricular and suprachiasmatic nuclei

Jolkkonen, J., Tuomisto, L. M., Greidanus, T. B. V. W., & Riekkinen, P. J. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90568-x · Cited by 34 · see citing works

VASOPRESSIN-DEPENDENT AND -INDEPENDENT CONTROL OF THE RELEASE OF ADRENOCORTICOTROPIN1

Carlson, D. E., Dornhorst, A., SEIF, S. M., ROBINSON, A. G., & Gann, D. S. (1982) · Endocrinology · doi:10.1210/endo-110-2-680 · Cited by 29 · see citing works

The Relative Importance of Hypothalamic Neurons Containing Corticotropin‐Releasing Factor or Vasopressin in the Regulation of Adrenocorticotropic Hormone Secretion

Makara, G. B. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514283.ch4 · Cited by 24 · see citing works

Treating Chronobiologic Sleep and Mood Disorders with Bright Light

Lewy, A. J. (1987) · Psychiatric Annals · doi:10.3928/0048-5713-19871001-09 · Cited by 22 · see citing works

The effect of a highly specific serotonin agonist on osmoregulated vasopressin secretion in healthy man

Faull, C., Rooke, P., & Baylis, P. H. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03560.x · Cited by 22 · see citing works

Chapter 30 Neurohypophyseal peptides and psychopathology

Legros, J. J., & Ansseau, M. (1992) · Progress in brain research · doi:10.1016/s0079-6123(08)64589-6 · Cited by 21 · see citing works

Influence of exogenously administered oxytocin on the corticosterone and prolactin response to psychological stress

Muir, J. L., & Pfister, H. P. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90190-6 · Cited by 20 · see citing works

Neurohypophyseal peptides and psychiatric diseases

Legros, J., Ansseau, M., & Timsit-Berthier, M. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90195-e · Cited by 18 · see citing works

Plasmatic vasopressin neurophysin in depression: Basic levels and relations with HPA axis

Laruelle, M. A., Seghers, A., Goffinet, S., Bouchez, S., & Legros, J. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90423-y · Cited by 14 · see citing works

Clinical management of the depressed geriatric patient: current therapeutic options.

MENDELS, J. (1993) · PubMed · Cited by 14 · see citing works

The Ultrastructural Localization of Amines, Amino Acids and Peptides in the Brain

Buijs, R. M. (1982) · Progress in brain research · doi:10.1016/s0079-6123(08)64196-5 · Cited by 13 · see citing works

Coexistence of CRF peptide and oxytocin mRNA in the paraventricular nucleus

Pretel, S., & Piekut, D. T. (1990) · Peptides · doi:10.1016/0196-9781(90)90068-g · Cited by 13 · see citing works

Increased neurophysin I and II cerebrospinal fluid concentrations from bipolar versus unipolar depressed patients.

Legros, J., Geenen, V. G., Linkowski, P., et al. (1983) · ORBi (University of Liège) · Cited by 11 · see citing works

The metabolic effects of oxytocin are mediated by a uterine type of receptor and are inhibited by oxytocin antagonist and by arginine vasopressin in the dog

ALTSZULER, N., Rosenberg, C. R., Winkler, B., et al. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90477-7 · Cited by 5 · see citing works

Stress and the brain: from adaptation to disease

de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621 · see citing works

The oxytocin receptor system: structure, function, and regulation

Gimpl, G., & Fahrenholz, F. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.629 · Cited by 3,089 · see citing works

The Corticosteroid Receptor Hypothesis of Depression

Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181 · see citing works

Physical Activity and Mental Health: Current Concepts

Paluska, S. A., & Schwenk, T. L. (2000) · Sports Medicine · doi:10.2165/00007256-200029030-00003 · Cited by 1,722 · see citing works

The oxytocin receptor: from intracellular signaling to behavior

Jurek, B., & Neumann, I. D. (2018) · Physiological Reviews · doi:10.1152/physrev.00031.2017 · Cited by 999 · see citing works

The stress system in the human brain in depression and neurodegeneration

Swaab, D. F., Bao, A.-M., & Lucassen, P. J. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.03.003 · Cited by 984 · see citing works

Oxytocin, vasopressin, and human social behavior

Heinrichs, M., von Dawans, B., & Domes, G. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.005 · Cited by 799 · see citing works

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

Holsboer, F. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)90056-5 · Cited by 654 · see citing works

In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice

Cryan, J. F., & Mombereau, C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001457 · Cited by 616 · see citing works

Stress, hypercortisolism and corticosteroid receptors in depression: implicatons for therapy

Holsboer, F. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00352-9 · Cited by 575 · see citing works

Chronic pain, chronic stress and depression: Coincidence or consequence?

Blackburn‐Munro, G., & Blackburn‐Munro, R. E. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.0007-1331.2001.00727.x · Cited by 493 · see citing works

Stress Hormone Regulation: Biological Role and Translation into Therapy

Holsboer, F., & Ising, M. (2010) · Annual Review of Psychology · doi:10.1146/annurev.psych.093008.100321 · Cited by 473 · see citing works

Is oxytocin “nature’s medicine”

Carter, C. S., Kenkel, W. M., MacLean, E. L., Wilson, S. R., Perkeybile, A. M., Yee, J. R., Ferris, C. F., Nazarloo, H. P., Porges, S. W., Davis, J. M., et al. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019398 · Cited by 394 · see citing works

Enlargement of the Amygdala in Patients with a First Episode of Major Depression

Frodl, T., Meisenzahl, E., Zetzsche, T., Bottlender, R., Born, C., Groll, C., Jäger, M., Leinsinger, G., Hahn, K., & Möller, H.-J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01359-2 · Cited by 316 · see citing works

Plasma Levels of Arginine Vasopressin Elevated in Patients with Major Depression

van Londen, L. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00054-7 · Cited by 306 · see citing works

Preliminary Research on Plasma Oxytocin in Normal Cycling Women: Investigating Emotion and Interpersonal Distress

Turner, R. A., Altemus, M., Enos, T., Cooper, B., & McGuinness, T. (1999) · Psychiatry · doi:10.1080/00332747.1999.11024859 · Cited by 298 · see citing works

Prosocial effects of oxytocin and clinical evidence for its therapeutic potential

Striepens, N., Kendrick, K. M., Maier, W., & Hurlemann, R. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2011.07.001 · Cited by 283 · see citing works

Oxytocin receptor polymorphisms and adult attachment style in patients with depression

Costa, B., Pini, S., Gabelloni, P., Abelli, M., Lari, L., Cardini, A., Muti, M., Gesi, C., Landi, S., Galderisi, S., et al. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.006 · Cited by 282 · see citing works

Cortisol and major depressive disorder-translating findings from humans to animal models and Back

Nandam, L. S., Brazel, M., Zhou, M., & Jhaveri, D. J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00974 · Cited by 265 · see citing works

Oxytocin, vasopressin, and autism: Is there a connection?

Insel, T. R., O’Brien, D. J., & Leckman, J. F. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00142-5 · Cited by 226 · see citing works

Evidence of dysregulated peripheral oxytocin release among depressed women

Cyranowski, J. M., Hofkens, T. L., Frank, E., Seltman, H., Cai, H.-M., & Amico, J. A. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318188ade4 · Cited by 220 · see citing works

The human hypothalamus in mood disorders: The HPA axis in the center

Bao, A.-M., & Swaab, D. F. (2019) · IBRO Reports · doi:10.1016/j.ibror.2018.11.008 · Cited by 212 · see citing works

An alternate pathway for androgen regulation of brain function: Activation of estrogen receptor beta by the metabolite of dihydrotestosterone, 5α-androstane-3β,17β-diol

Handa, R. J., Pak, T. R., Kudwa, A. E., Lund, T. D., & Hinds, L. (2008) · Hormones and Behavior · doi:10.1016/j.yhbeh.2007.09.012 · Cited by 205 · see citing works

Circadian Rhythm Disturbances in Mood Disorders: Insights into the Role of the Suprachiasmatic Nucleus

Vadnie, C. A., & McClung, C. A. (2017) · Neural Plasticity · doi:10.1155/2017/1504507 · Cited by 199 · see citing works

Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?

Griebel, G., & Holsboer, F. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3702 · Cited by 194 · see citing works

Oxytocin receptors in the anteromedial bed nucleus of the stria terminalis promote stress-induced social avoidance in female California mice

Duque-Wilckens, N., Steinman, M. Q., Busnelli, M., Chini, B., Yokoyama, S., Pham, M., Laredo, S. A., Hao, R., Perkeybile, A. M., Minie, V. A., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.024 · Cited by 181 · see citing works

Endocrine withdrawal syndromes

Hochberg, Z., Pacak, K., & Chrousos, G. P. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0014 · Cited by 181 · see citing works

Neuroendocrinological mechanisms of actions of antidepressant drugs

Schüle, C. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01516.x · Cited by 167 · see citing works

Elevated neuron number in the limbic thalamus in major depression

Young, K. A., Holcomb, L. A., Yazdani, U., Hicks, P. B., & German, D. C. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1270 · Cited by 169 · see citing works

Preliminary evidence that plasma oxytocin levels are elevated in major depression

Parker, K. J., Kenna, H. A., Zeitzer, J. M., Keller, J., Blasey, C. M., Amico, J. A., & Schatzberg, A. F. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.09.017 · Cited by 163 · see citing works

High prevalence of chronic pituitary and target-organ hormone abnormalities after blast-related mild traumatic brain injury

Wilkinson, C. W., Pagulayan, K. F., Petrie, E. C., Mayer, C. L., Colasurdo, E. A., Shofer, J. B., Hart, K. L., Hoff, D., Tarabochia, M. A., & Peskind, E. R. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00011 · Cited by 162 · see citing works

Oxytocin and Vasopressin in Children and Adolescents With Autism Spectrum Disorders: Sex Differences and Associations With Symptoms

Miller, M., Bales, K. L., Taylor, S. L., Yoon, J., Hostetler, C. M., Carter, C. S., & Solomon, M. (2013) · Autism Research · doi:10.1002/aur.1270 · Cited by 151 · see citing works

Breaking bonds in male prairie vole: Long-term effects on emotional and social behavior, physiology, and neurochemistry

Sun, P., Smith, A. S., Lei, K., Liu, Y., & Wang, Z. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.02.016 · Cited by 141 · see citing works

Roles of Oxytocin Neurones in the Control of Stress, Energy Metabolism, and Social Behaviour

Onaka, T., Takayanagi, Y., & Yoshida, M. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02300.x · Cited by 123 · see citing works

Increased Arginine Vasopressin mRNA Expression in the Human Hypothalamus in Depression: A Preliminary Report

Meynen, G., Unmehopa, U. A., van Heerikhuize, J. J., Hofman, M. A., Swaab, D. F., & Hoogendijk, W. J. G. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.12.010 · Cited by 108 · see citing works

Evidence That 5-HT_2AReceptors in the Hypothalamic Paraventricular Nucleus Mediate Neuroendocrine Responses to (−)DOI

Zhang, Y., Damjanoska, K. J., Carrasco, G. A., Dudas, B., D'Souza, D. N., Tetzlaff, J., Garcia, F., Hanley, N. R. S., Scripathirathan, K., Petersen, B. R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09635.2002 · Cited by 107 · see citing works

The impact of treatment on HPA axis activity in unipolar major depression

McKay, M. S., & Zakzanis, K. K. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.07.012 · Cited by 103 · see citing works

Cerebrospinal fluid levels of oxytocin in Prader–Willi syndrome: a preliminary report

Martin, A., State, M., Anderson, G. M., Kaye, W. M., Hanchett, J. M., McConaha, C. W., North, W. G., & Leckman, J. F. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00190-5 · Cited by 89 · see citing works

The Vasopressin V_1bReceptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies

Griebel, G., Beeské, S., & Stahl, S. M. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07804 · Cited by 81 · see citing works

An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP

CONNAN, F., LIGHTMAN, S., LANDAU, S., WHEELER, M., TREASURE, J., & CAMPBELL, I. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.12.005 · Cited by 80 · see citing works

Cellular abnormalities in depression: evidence from postmortem brain tissue

Stockmeier, C. A., & Rajkowska, G. (2004) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2004.6.2/cstockmeier · Cited by 67 · see citing works

Coping style moderates the effect of intranasal oxytocin on the mood response to interpersonal stress

Cardoso, C., Linnen, A.-M., Joober, R., & Ellenbogen, M. A. (2012) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0025763 · Cited by 60 · see citing works

Oxytocin receptor mRNA expression in dorsolateral prefrontal cortex in major psychiatric disorders: A human post-mortem study

Lee, M. R., Sheskier, M. B., Farokhnia, M., Feng, N., Marenco, S., Lipska, B. K., & Leggio, L. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.05.039 · Cited by 44 · see citing works

Blockade of the V1b receptor reduces ACTH, but not corticosterone secretion induced by stress without affecting basal hypothalamic–pituitary–adrenal axis activity

Spiga, F., Harrison, L. R., Wood, S., Knight, D. M., MacSweeney, C. P., Thomson, F., Craighead, M., & Lightman, S. L. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0421 · Cited by 40 · see citing works

Vasopressin V1B receptor antagonists as potential antidepressants

Chaki, S. (2021) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab013 · Cited by 34 · see citing works

Pharmacokinetics and metabolism of SRX246: a potent and selective vasopressin 1a antagonist

Fabio, K. M., Guillon, C. D., Lu, S.-F., Heindel, N. D., Brownstein, M. J., Lacey, C. J., Garippa, C., & Simon, N. G. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23495 · Cited by 34 · see citing works

Characterization of a novel vasopressin V1b receptor antagonist, V1B-30N, in animal models of anxiety-like and depression-like behavior

Hodgson, R. A., Mullins, D., Lu, S. X., Guzzi, M., Zhang, X., Bleickardt, C. J., Scott, J. D., Miller, M. W., Stamford, A. W., Parker, E. M., et al. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.02.027 · Cited by 30 · see citing works

Efficacy and safety of TS-121, a novel vasopressin V1B receptor antagonist, as adjunctive treatment for patients with major depressive disorder: A randomized, double-blind, placebo-controlled study

Kamiya, M., Sabia, H. D., Marella, J., Fava, M., Nemeroff, C. B., Umeuchi, H., Iijima, M., Chaki, S., & Nishino, I. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.05.017 · Cited by 28 · see citing works

Vasopressin–neurophysin and DST in major depression: Relationship with suicidal behavior

Pitchot, W., Scantamburlo, G., Pinto, E., Hansenne, M., Reggers, J., Ansseau, M., & Legros, J.-J. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.07.007 · Cited by 26 · see citing works

Hypothalamic stress systems in mood disorders

(2021) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-819973-2.00003-4 · Cited by 15 · see citing works

Uterine Contractile Activity Stimulates Supraoptic Neurons in Term Pregnant Rats Via a Noradrenergic Pathway**This work was supported by The Wellcome Trust (Project Grant 047318/Z/96/Z) and the Biotechnology and Biological Sciences Research Council.

Douglas, A. J., Scullion, S., Antonijevic, I. A., Brown, D., Russell, J. A., & Leng, G. (2001) · Endocrinology · doi:10.1210/endo.142.2.7962 · Cited by 59 · see citing works

Pituitary Oxytocin and Vasopressin Content of Pregnant Rats Before, During, and After Parturition

Fuchs, A., & Saito, S. (1971) · Endocrinology · doi:10.1210/endo-88-3-574 · Cited by 78 · see citing works

Oxytocin as well as vasopressin potentiate ovine CRF in vitro

Antoni, F. A., Holmes, M. C., & Jones, M. T. (1983) · Peptides · doi:10.1016/0196-9781(83)90041-4 · Cited by 120 · see citing works

Oxytocin Released within the Supraoptic Nucleus of the Rat Brain by Positive Feedback Action is Involved in Parturition‐Related Events

Neumann, I. D., Douglas, A. J., Pittman, Q. J., Russell, J. A., & Landgraf, R. (1996) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1996.04557.x · Cited by 159 · see citing works

Hypotension preferentially induces c-fos immunoreactivity in supraoptic vasopressin neurons

Shen, E., Dun, S. L., Bennett‐Clarke, C. A., & Dun, N. J. (1992) · Brain Research · doi:10.1016/0006-8993(92)91275-j · Cited by 60 · see citing works